These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29046167)

  • 1. Non-SMC Condensin I Complex, Subunit G (NCAPG) is a Novel Mitotic Gene Required for Hepatocellular Cancer Cell Proliferation and Migration.
    Zhang Q; Su R; Shan C; Gao C; Wu P
    Oncol Res; 2018 Mar; 26(2):269-276. PubMed ID: 29046167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth.
    Wang Y; Gao B; Tan PY; Handoko YA; Sekar K; Deivasigamani A; Seshachalam VP; OuYang HY; Shi M; Xie C; Goh BKP; Ooi LL; Man Hui K
    FASEB J; 2019 Aug; 33(8):8759-8770. PubMed ID: 31022357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing non-SMC chromosome-associated polypeptide G inhibits proliferation and induces apoptosis in hepatocellular carcinoma cells.
    Liu K; Li Y; Yu B; Wang F; Mi T; Zhao Y
    Can J Physiol Pharmacol; 2018 Dec; 96(12):1246-1254. PubMed ID: 30089216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of non‑SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma.
    Liu W; Liang B; Liu H; Huang Y; Yin X; Zhou F; Yu X; Feng Q; Li E; Zou Z; Wu L
    Int J Mol Med; 2017 Sep; 40(3):731-738. PubMed ID: 28737823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NCAPG is a prognostic biomarker associated with vascular invasion in hepatocellular carcinoma.
    Guo ZY; Zhu ZT
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7238-7251. PubMed ID: 34919223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-SMC condensin I complex subunit H enhances proliferation, migration, and invasion of hepatocellular carcinoma.
    Sun C; Huang S; Wang H; Xie R; Zhang L; Zhou Q; He X; Ju W
    Mol Carcinog; 2019 Dec; 58(12):2266-2275. PubMed ID: 31523845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance.
    Emma MR; Iovanna JL; Bachvarov D; Puleio R; Loria GR; Augello G; Candido S; Libra M; Gulino A; Cancila V; McCubrey JA; Montalto G; Cervello M
    Cell Death Dis; 2016 Jun; 7(6):e2269. PubMed ID: 27336713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SKA3 Promotes tumor growth by regulating CDK2/P53 phosphorylation in hepatocellular carcinoma.
    Hou Y; Wang Z; Huang S; Sun C; Zhao J; Shi J; Li Z; Wang Z; He X; Tam NL; Wu L
    Cell Death Dis; 2019 Dec; 10(12):929. PubMed ID: 31804459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RAB10 overexpression promotes tumor growth and indicates poor prognosis of hepatocellular carcinoma.
    Wang W; Jia WD; Hu B; Pan YY
    Oncotarget; 2017 Apr; 8(16):26434-26447. PubMed ID: 28460436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of NCAPG by miR-99a-3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC.
    Arai T; Okato A; Yamada Y; Sugawara S; Kurozumi A; Kojima S; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Cancer Med; 2018 May; 7(5):1988-2002. PubMed ID: 29608247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
    He F; Li J; Xu J; Zhang S; Xu Y; Zhao W; Yin Z; Wang X
    J Exp Clin Cancer Res; 2015 May; 34(1):47. PubMed ID: 25975202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of hematological and neurological expressed 1 (HN1) is associated with a poor prognosis of hepatocellular carcinoma and its knockdown inhibits cell growth and migration partly by down-regulation of c-Met.
    Chen JJ; Sun X; Mao QQ; Jiang XY; Zhao XG; Xu WJ; Zhong L
    Kaohsiung J Med Sci; 2020 Mar; 36(3):196-205. PubMed ID: 31749294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
    PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC).
    Tian Y; Wu J; Chagas C; Du Y; Lyu H; He Y; Qi S; Peng Y; Hu J
    BMC Cancer; 2018 Nov; 18(1):1187. PubMed ID: 30497429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WTAP facilitates progression of hepatocellular carcinoma via m6A-HuR-dependent epigenetic silencing of ETS1.
    Chen Y; Peng C; Chen J; Chen D; Yang B; He B; Hu W; Zhang Y; Liu H; Dai L; Xie H; Zhou L; Wu J; Zheng S
    Mol Cancer; 2019 Aug; 18(1):127. PubMed ID: 31438961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF2 Is Up-regulated by Epigenetic Mechanisms in Hepatocellular Carcinomas and Is an Actionable Oncogene Product in Experimental Models.
    Martinez-Quetglas I; Pinyol R; Dauch D; Torrecilla S; Tovar V; Moeini A; Alsinet C; Portela A; Rodriguez-Carunchio L; Solé M; Lujambio A; Villanueva A; Thung S; Esteller M; Zender L; Llovet JM
    Gastroenterology; 2016 Dec; 151(6):1192-1205. PubMed ID: 27614046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin B2 Overexpression in Human Hepatocellular Carcinoma is Associated with Poor Prognosis.
    Li R; Jiang X; Zhang Y; Wang S; Chen X; Yu X; Ma J; Huang X
    Arch Med Res; 2019 Jan; 50(1):10-17. PubMed ID: 31101236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.
    Lv J; Zhang S; Wu H; Lu J; Lu Y; Wang F; Zhao W; Zhan P; Lu J; Fang Q; Xie C; Yin Z
    Cancer Lett; 2020 Jan; 469():22-34. PubMed ID: 31634528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human alkaline ceramidase 2 promotes the growth, invasion, and migration of hepatocellular carcinoma cells via sphingomyelin phosphodiesterase acid-like 3B.
    Liu B; Xiao J; Dong M; Qiu Z; Jin J
    Cancer Sci; 2020 Jul; 111(7):2259-2274. PubMed ID: 32391585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.